Vaginal Probiotics: Real Benefits or Hype
Health LibraryStrategies for Menstrual Health and Comfort
Vaginal Probiotics: Real Benefits or Hype

The topic of vaginal probiotics has garnered significant attention in both medical research and public discourse, focusing on their role in maintaining vaginal health and preventing infections. This blog will explore the scientific evidence surrounding vaginal probiotics, distinguishing between substantiated claims and areas where more research is needed. We will reference key publications from reputable databases, primarily focusing on NCBI and other medical research outlets, to ensure accuracy and reliability.

What Are Vaginal Probiotics?

Vaginal probiotics are formulations containing specific strains of live bacteria intended to support the natural flora of the vagina. The primary goal of these probiotics is to restore and maintain a healthy balance of microorganisms, potentially preventing common issues like bacterial vaginosis (BV), yeast infections, and urinary tract infections (UTIs).

Scientific Evidence: Real Benefits or Hype?

Prevention of Bacterial Vaginosis and Yeast Infections

A meta-analysis, covering studies up to March 1, 2018, evaluated the efficacy and safety of probiotics in treating bacterial vaginosis (BV). Including ten randomized controlled trials with 2,321 participants, the analysis found that probiotics significantly improved clinical cure rates and Nugent scores for BV at 30 days compared to placebo. This beneficial effect persisted, though diminished, after eight weeks. While probiotics used post-antibiotics showed a short-term effect, particularly in studies with primarily black populations, no additional adverse events were reported. The study suggests probiotics are a safe, effective treatment for BV, but highlights the need for larger trials to confirm these findings, especially regarding ethnic-specific responses.

Impact on Urinary Tract Infections

In a study spanning from 2005 to 2008, 176 premenopausal women with UTI histories were randomized to receive either cranberry juice or a placebo daily. The investigation aimed to compare UTI occurrence, asymptomatic bacteriuria rates, and the presence of urinary P-fimbriated E. coli over six months. Results showed no significant difference in UTI rates between the cranberry and placebo groups. However, there was a non-significant trend suggesting a potential protective effect of cranberry juice against UTIs and a reduction in P-fimbriated E. coli strains. Despite these findings, cranberry juice did not significantly lower UTI risk compared to placebo.

Improving Vaginal Health During Antibiotic Use

The study published in 2009 investigates the effectiveness of probiotic lactobacilli in enhancing the treatment of vulvovaginal candidiasis (VVC) through a randomized, double-blind, placebo-controlled trial. Fifty-five women diagnosed with VVC were treated with a single dose of fluconazole (150 mg), followed by a 4-week regimen of either two placebo or two probiotic capsules containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Results indicated a significant reduction in vaginal discharge and yeast presence in the probiotic group compared to the placebo group at the 4-week mark. This study demonstrates the potential of probiotic lactobacilli to improve anti-fungal treatment outcomes for VVC, suggesting an innovative approach to managing this common condition.

Areas Requiring Further Research

While there is promising evidence supporting the use of vaginal probiotics for certain conditions, more research is needed in several areas, including:

  • Long-term safety and efficacy of vaginal probiotic use.
  • The impact of probiotics on the vaginal microbiome in diverse populations.
  • Optimal strains and dosages for specific conditions.

Conclusion: Real Thing, but with Caveats

Based on current scientific evidence, vaginal probiotics offer real benefits for certain conditions, such as preventing BV, UTIs, and maintaining vaginal health, especially during antibiotic use. However, it's important to approach this topic with a critical eye, recognizing areas where more research is needed to fully understand their role and efficacy.

It's also crucial for consumers to consult healthcare providers before starting any new supplement, including probiotics, to ensure it's appropriate for their individual health needs.

References
  • Wang Z, He Y, Zheng Y. Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis. Int J Environ Res Public Health. 2019 Oct 12;16(20):3859. doi: 10.3390/ijerph16203859. PMID: 31614736; PMCID: PMC6848925.
  • Ziyadi S., Homayouni A., Mohammad-Alizadeh-Charandabi S., Bastani P. Probiotics Prebiotics & Synbiotics. Elsevier Inc.; Amsterdam, The Netherlands: 2016. Chapter 49—Probiotics and Usage in Bacterial Vaginosis; pp. 55–659.
  • Goldenberg R.L., Klebanoff M.A., Nugent R., Krohn M.A., Hillier S., Andrews W.W. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am. J. Obstet. Gynecol. 1996;174:1618–1621. doi: 10.1016/S0002-9378(96)70617-8.
  • Wang Y, Liu Z, Chen T. Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection. Heliyon. 2024 Mar 2;10(5):e27239. doi: 10.1016/j.heliyon.2024.e27239. PMID: 38463778; PMCID: PMC10923723.
  • Song J, Dong X, Lan Y, Lu Y, Liu X, Kang X, Huang Z, Yue B, Liu Y, Ma W, Zhang L, Yan H, He M, Fan Z, Guo T. Interpretation of vaginal metagenomic characteristics in different types of vaginitis. mSystems. 2024 Mar 19;9(3):e0137723. doi: 10.1128/msystems.01377-23. Epub 2024 Feb 16. PMID: 38364107; PMCID: PMC10949516.
  • Lundberg G, Wu P, Wenger N. Menopausal Hormone Therapy: a Comprehensive Review. Curr Atheroscler Rep. 2020 Jun 18;22(8):33. doi: 10.1007/s11883-020-00854-8. PMID: 32556827.
  • Boahen A, Than LTL, Loke YL, Chew SY. The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections. Front Microbiol. 2022 May 26;13:787119. doi: 10.3389/fmicb.2022.787119. PMID: 35694318; PMCID: PMC9179178.
  • Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarova-Yarovaya Y, Chen S, Gupta K. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc. 2012 Feb;87(2):143-50. doi: 10.1016/j.mayocp.2011.10.006. PMID: 22305026; PMCID: PMC3497550.
  • Bolgarina Z, Gonzalez-Gonzalez LF, Rodroiguez GV, Camacho A. Cranberry Supplements for Urinary Tract Infection Prophylaxis in Pregnant Women: A Systematic Review of Clinical Trials and Observational Studies on Efficacy, Acceptability, Outcomes Measurement Methods, and Studies' Feasibility. Cureus. 2023 Oct 9;15(10):e46738. doi: 10.7759/cureus.46738. Erratum in: Cureus. 2023 Oct 16;15(10):c140. PMID: 38022216; PMCID: PMC10631496.
  • Williams G, Stothart CI, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Nov 10;11(11):CD001321. doi: 10.1002/14651858.CD001321.pub7. PMID: 37947276; PMCID: PMC10636779.
  • Xiao B, A D, Qin H, Mi L, Zhang D. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis. Front Cell Infect Microbiol. 2022 Mar 8;12:860589. doi: 10.3389/fcimb.2022.860589. PMID: 35372135; PMCID: PMC8970117.
  • Mändar R, Sõerunurk G, Štšepetova J, Smidt I, Rööp T, Kõljalg S, Saare M, Ausmees K, Le DD, Jaagura M, Piiskop S, Tamm H, Salumets A. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. Benef Microbes. 2023 Apr 18;14(2):143-152. doi: 10.3920/BM2022.0091. Epub 2023 Mar 1. PMID: 36856121.
IN THIS ARTICLE
1.What Are Vaginal Probiotics?
2.Scientific Evidence: Real Benefits or Hype?
3.Areas Requiring Further Research
4.Conclusion: Real Thing, but with Caveats